{
    "success": true,
    "data": {
        "leverage": false,
        "derivatives": false,
        "swaps": false,
        "inverse": false,
        "replication_method": "physical",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [],
        "classification": "non-complex",
        "supporting_data": "The Sub-Fund is explicitly identified as a 'UCITS ETF', which benefits from a presumption of non-complexity under MiFID II (CESR/09-295, Section IV, Para 69). Its primary investment strategy is 'Direct Replication', meaning it aims to track its index by holding the underlying securities, a key characteristic of non-complex ETFs. The use of 'derivatives' is stated to be for 'efficient portfolio management (EPM)', specifically 'to deal with inflows and outflows and also if it allows a better exposition to an Index constituent'. This falls under risk management rather than being an inherent element of the strategy, which leads to 'derivatives' being 'false' as per the specific instruction. Critically, the Key Investor Information document does not explicitly mention 'swap usage', which, if identified, would automatically classify the ETF as complex according to the provided strict rule. While 'Counterparty risk' is listed as a relevant risk, a common disclosure for funds engaging in EPM or securities lending, it does not by itself override the non-complex classification given the physical replication and the EPM nature of derivative use. The underlying 'Bloomberg BioEnergy ESG Index' appears transparent and is based on companies in a specific sector, not on complex financial instruments or strategies like those involving 'roll costs', 'contango', or 'backwardation effects'. The ETF does not employ significant leverage, offer capital protection through complex structures, or invest in Contingent Convertible Bonds."
    }
}